Our findings support the idea that this rare concurrence of AML and untreated CLL may represent two separate disease processes as CLL arises from abnormal population of CD5+, CD19+ B lymphocytes whereas AML derives from an abnormal myeloid precursor. This evidence concerns the gene CD5 and acute myeloid leukemia.